Barrow Hanley Mewhinney & Strauss LLC decreased its position in Transcat, Inc. (NASDAQ:TRNS – Free Report) by 5.0% in the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 380,176 shares of the scientific and technical instruments company’s stock after selling 19,807 shares during the period. Barrow Hanley Mewhinney & Strauss LLC owned 4.04% of Transcat worth $33,615,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Roubaix Capital LLC acquired a new position in Transcat during the third quarter valued at $2,794,000. White Pine Capital LLC purchased a new position in shares of Transcat during the 3rd quarter worth $1,710,000. Russell Investments Group Ltd. grew its position in Transcat by 41.8% in the 3rd quarter. Russell Investments Group Ltd. now owns 24,929 shares of the scientific and technical instruments company’s stock valued at $2,204,000 after acquiring an additional 7,348 shares in the last quarter. R Squared Ltd purchased a new stake in shares of Transcat during the third quarter worth $274,000. Finally, Riverbridge Partners LLC lifted its position in shares of Transcat by 8.4% during the 3rd quarter. Riverbridge Partners LLC now owns 219,452 shares of the scientific and technical instruments company’s stock worth $19,404,000 after purchasing an additional 17,063 shares during the last quarter. 98.34% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
TRNS has been the topic of several recent research reports. Oppenheimer upgraded shares of Transcat from a “market perform” rating to an “outperform” rating and set a $115.00 price objective on the stock in a research report on Wednesday, November 4th. CJS Securities began coverage on Transcat in a research note on Tuesday, October 27th. They set an “outperform” rating and a $115.00 price objective on the stock. Northland Securities raised Transcat from a “market perform” rating to an “outperform” rating and set a $95.00 target price on the stock in a research note on Wednesday, October 21st. Zacks Research raised Transcat from a “hold” rating to a “strong-buy” rating in a report on Thursday, November 5th. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of Transcat in a research note on Tuesday, August 25th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has issued a Sell rating to the company. According to MarketBeat.com, Transcat presently has a consensus rating of “Moderate Buy” and a consensus price target of $108.33.
Insider Buying and Selling at Transcat
In related news, CEO Jaime A. Irick purchased 2,275 shares of the business’s stock in a transaction that occurred on Thursday, November 5th. The stock was acquired at an average cost of $101.26 per share, for a total transaction of $230,366.50. Following the completion of the purchase, the chief executive officer owned 2,275 shares in the company, valued at approximately $230,366.50. This represents a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 1.80% of the company’s stock.
Transcat Trading Down 4.7%
Shares of TRNS opened at $92.97 on Friday. The company has a quick ratio of 2.19, a current ratio of 2.57 and a debt-to-equity ratio of 0.38. Transcat, Inc. has a 12-month low of $50.23 and a 12-month high of $112.44. The firm has a market capitalization of $873.92 million, a PE ratio of 193.69 and a beta of 0.61. The stock’s fifty day simple moving average is $90.46 and its 200-day simple moving average is $84.47.
Transcat (NASDAQ:TRNS – Get Free Report) last issued its quarterly earnings data on Tuesday, November 3rd. The scientific and technical instruments company reported $0.64 EPS for the quarter, topping the consensus estimate of $0.45 by $0.19. The business had revenue of $97.09 million for the quarter, compared to the consensus estimate of $92.46 million. Transcat had a return on equity of 6.14% and a net margin of 1.26%. As a group, research analysts predict that Transcat, Inc. will post 2.06 earnings per share for the current year.
Transcat Company Profile
Transcat, Inc. provides calibration and related services, including instrument repair, inspection and compliance support. Its services help customers maintain the accuracy and reliability of equipment used in regulated and quality-sensitive operations. The company also distributes professional-grade test, measurement and control instruments from a range of manufacturers. Its offerings include equipment used to measure and monitor variables such as pressure, temperature, electrical signals and humidity.
See Also
- Five stocks we like better than Transcat
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.
